Harvard Bioscience (HBIO) Curent Deferred Tax Liability (2014 - 2015)

Harvard Bioscience (HBIO) has reported Curent Deferred Tax Liability for 2 consecutive years, with $2.2 million the latest figure, recorded in Q4 2015.

• In Q4 2015, Curent Deferred Tax Liability rose 1756.2% year-over-year to $2.2 million; the TTM figure through Dec 2015 stood at $2.2 million (up 1756.2% YoY), while the FY2015 annual figure was $2.2 million, up 1756.2% from the prior year.
• Curent Deferred Tax Liability grew to $2.2 million in Q4 2015 per HBIO's latest filing, from $244000.0 in the prior quarter.
• Across five years, Curent Deferred Tax Liability topped out at $2.2 million in Q4 2015 and bottomed at $121000.0 in Q4 2014.